Search Results

Site Search

From Pediatrics to Geriatrics [Pediatric Phlebotomy] - Insights

This "Pediatric Phlebotomy" presentation from the live 2017 Phlebotomy Conference, will focus on the challenges associated with age-related collections, dealing specifically with both the pediatric and geriatric patient.

Updated authentication for MayoACCESS client test environment - Insights

Mayo Clinic Laboratories will be migrating the MayoACCESS application to the authentication service used across Mayo Clinic.

Clinical Application of Next-Generation Sequencing (NGS) Testing - Insights

October 8, 2017 | Rochester, Minnesota This symposium is designed for any provider who treats patients with hematologic malignancies (e.g., oncologists, hematologists, and physician assistants), pathologists, hematopathologists,...

Hematology, oncology, and hereditary test selection guide - Insights

The Hematology, Oncology, and Hereditary Test Selection Guide lets you search our next-generation sequencing test menu and choose the right panels for patients.

Nailing the Suspect: The Prevalence of Autoimmune Encephalitis Compared with Infectious Encephalitis - Insights

For people with encephalitis, rapid treatment of their acute brain inflammation is critical for avoiding devastating physical and cognitive deficits. But appropriate treatment requires identifying the culprit causing the symptoms.

Ceramide testing helps reduce risk of heart attack: Stephanie Blendermann - Insights

Her father was a heavy smoker who eventually needed bypass surgery for his clogged arteries, and three of her sisters died prematurely from heart attacks. So, as Stephanie Blendermann approached the age of 65, she had good reason to think...

Detecting danger: Dan O'Bryan - Insights

Dan O’Bryan didn’t think his dizziness and lightheadedness were anything to worry about. Nearly 100 miles away, the team at Mayo Clinic that was remotely monitoring Dan’s heart could see the truth.

Modified two-tiered testing for Lyme disease - Insights

In this month’s “Hot Topic,” Elitza Theel, Ph.D., discusses the modified two-tiered testing algorithm for Lyme disease entirely based on enzyme immunoassays (EIA).

Next-generation sequencing: Examining an often oversimplified & misunderstood technology-Part II - Insights

One of the biggest misunderstandings about genetic testing is a perception that once a variant is identified and analyzed thoroughly, using all the best tools available, it can be associated with a specific disease or condition. But many...

Ceramide testing helps shape individualized heart health treatment plan: Mark Kocak - Insights

An avid runner and fitness buff, Mark Kocak didn’t think he needed medication for his high cholesterol and hypertension. After coming to Mayo Clinic for ceramide testing, Mark knew exercise alone would not be enough to him on a path toward...